Gwost J, Stoebe T, Chesler E, Weir E K
Cathet Cardiovasc Diagn. 1982;8(1):13-21. doi: 10.1002/ccd.1810080104.
The mortality and morbidity associated with cardiac catheterization at the Minneapolis VA Medical Center has been analysed over a period of nine years (1971-1979) in order to identify correctable problem, obtain accurate data for patient information, and allow comparison with other institutions. In common with reports from other catheter laboratories, the mortality has fallen from 0.74% (952 patients) between 1971 and 1975 to 0.24% (819) patients between 1976 and 1979. There has been a similar decline in the combined incidence of myocardial infarction and cerebral embolism from 1.05% to 0.24% over the same period. Our patients with ischemic heart disease included many at high risk of complications in that three vessel disease was present in 53% and the ejection fraction was less than 50% in 24% of cases. In order to ensure that the best standards of cardiac catheterization are maintained, we agree with a recent suggestion that there should be a national surveillance program monitoring fatality and complication rates in all catheterization laboratories.
为了找出可纠正的问题、获取准确的患者信息数据并与其他机构进行比较，明尼阿波利斯退伍军人事务医疗中心对九年（1971 - 1979年）期间与心导管插入术相关的死亡率和发病率进行了分析。与其他导管实验室的报告一样，死亡率从1971年至1975年期间的0.74%（952例患者）降至1976年至1979年期间的0.24%（819例患者）。同期心肌梗死和脑栓塞的合并发生率也从1.05%降至0.24%。我们的缺血性心脏病患者中有许多人并发症风险很高，因为53%的患者存在三支血管病变，24%的病例射血分数低于50%。为了确保维持心导管插入术的最佳标准，我们赞同最近的一项建议，即应设立一项全国性监测计划，监测所有导管实验室的死亡率和并发症发生率。
